The reduction in hepatic steatosis in DHA-fed fa/fa Zucker rats was associated with the lowest levels of a fibrosis marker (α-SMA); furthermore, the 5-fold reduction of α-SMA from baseline by DHA indicates that reversal of early fibrotic damage is possible. The gene discussed is ACTA1; the disease is fatty liver disease.